Patient Guide: FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 25 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04768972
Status: ACTIVE_NOT_RECRUITING
Condition: Amyotrophic Lateral Sclerosis
Phase: PHASE3

Where You Can Participate

This study is available at 25 locations across the country.

Top locations include:
  • • La Jolla, California
  • • Palo Alto, California
  • • Baltimore, Maryland
  • • And 22 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS) - Join Clinical Trial NCTNCT04768972

How to Join This Clinical Trial - NCTNCT04768972

Learn how to participate in this PHASE3 trial studying an investigational therapy for Amyotrophic Lateral Sclerosis. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Amyotrophic Lateral Sclerosis. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Amyotrophic Lateral Sclerosis
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04768972 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 25 locations. Find a study site near you:

Clinical Research Site

La Jolla, California 92037 - United States

Status: Contact for availability

Clinical Research Site

Palo Alto, California 94304 - United States

Status: Contact for availability

Clinical Research Site

Baltimore, Maryland 21205 - United States

Status: Contact for availability

Clinical Research Site

Boston, Massachusetts 02114 - United States

Status: Contact for availability

Clinical Research Site

Saint Louis, Missouri 63110 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10032 - United States

Status: Contact for availability

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: Contact for availability

Clinical Research Site

Salt Lake City, Utah 84132 - United States

Status: Contact for availability

Clinical Research Site

Leuven, VL-Brabant 3000 - Belgium

Status: Contact for availability

Clinical Research Site

São Paulo, 04038-002 - Brazil

Status: Contact for availability

And 15 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Amyotrophic Lateral Sclerosis:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships